Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

  • Author(s): Long, SA;
  • Rieck, M;
  • Sanda, S;
  • Bollyky, JB;
  • Samuels, PL;
  • Goland, R;
  • Ahmann, A;
  • Rabinovitch, A;
  • Aggarwal, S;
  • Phippard, D;
  • Turka, LA;
  • Ehlers, MR;
  • Bianchine, PJ;
  • Boyle, KD;
  • Adah, SA;
  • Bluestone, JA;
  • Buckner, JH;
  • Greenbaum, CJ
  • et al.
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View